Immuron (IMRN) Payables (2016 - 2026)
Immuron (IMRN) posted Payables of $1.3 million for Q3 2026, down 12.03% on a QoQ basis from $1.5 million in Q4 2025, and up 8697.27% year-over-year from $15294.3 in Q3 2025.
Analysis
Immuron (IMRN) Payables (2016 - 2026) Analysis & Trends
Immuron has reported Payables for 11 years, with the latest figure at $1.3 million in Q3 2026.
- On a quarterly basis, Payables rose 8697.27% year-over-year to $1.3 million in Q3 2026; TTM through Aug 2026 was $1.3 million, a 8697.27% increase from a year earlier, with the FY2026 full-year figure at $1.3 million, up 8697.27% from the prior year.
- Payables was $1.3 million for Q3 2026 at Immuron, down from $1.5 million in the prior quarter.
- The five-year high for Payables was $1.5 million in Q4 2025, with the low at $11927.7 in Q3 2023.
- Average Payables over 5 years is $818377.1, with a median of $802255.6 recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: Payables sank 98.52% in 2023, then soared 8697.27% in 2026.
- Over 5 years, Payables stood at $762732.0 in 2022, then increased by 1.8% to $776481.3 in 2023, then jumped by 79.88% to $1.4 million in 2024, then grew by 9.5% to $1.5 million in 2025, then decreased by 12.03% to $1.3 million in 2026.
- The last three Payables figures came in at $1.3 million (Q3 2026), $1.5 million (Q4 2025), and $15294.3 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | 1.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 2, 2025 | 15,294.34 |
| Jun 30, 2025 | 979,500.96 |
| Dec 31, 2024 | 1.40 Mn |
| Sep 9, 2024 | 14,231.93 |
| Jun 30, 2024 | 1.41 Mn |
| Dec 31, 2023 | 776,481.26 |
| Sep 28, 2023 | 781,835.96 |
| Aug 30, 2023 | 11,927.69 |
| Jun 30, 2023 | 797,199.62 |
| Dec 31, 2022 | 762,732.01 |
| Aug 31, 2022 | 807,311.55 |
| Jun 30, 2022 | 831,510.88 |
| Dec 31, 2021 | 555,231.32 |
| Sep 30, 2021 | 557,740.42 |
| Jun 30, 2021 | 584,082.20 |
| Dec 31, 2020 | 280,969.13 |
| Sep 1, 2020 | 384,397.00 |
| Jun 30, 2020 | 251,941.72 |